HealthcareMRR2

Biobanking Market The biobanking market size was valued USD 69.5 billion in 2022 and is expected to reach USD 93.3 billion by 2032 at 4.2% CAGR during the forecast period 2023-2032. Market Drivers and Key Restraints The global biobanking market is undergoing massive evolution in the form of technological innovations in genetic tools, which help elevate the demand for high-quality biospecimens used for enhancing cancer research. Citing a reference, Northwell Health had partnered with Indivumed in January 2017 for creating a cancer research biobank. In addition, the current developments in information technology as well as automation solutions have enhanced the efficiency of the biobanking services. For instance, with the launch of fully automated programmed freezers as well as refrigerators, the temperature monitoring in biobanks has become far more efficient than before. Additionally, technological developments in biotechnology workflows have led to a growth in the applicat...

Biobanking Market The biobanking market size was valued 72.41 Billion in 2023 and is expected to reach USD 92.69 billion by 2030 at 4.2% CAGR during the forecast period 2023-2030. Market Drivers and Key Restraints The global biobanking market is undergoing massive evolution in the form of technological innovations in genetic tools, which help elevate the demand for high-quality biospecimens used for enhancing cancer research. Citing a reference, Northwell Health had partnered with Indivumed in January 2017 for creating a cancer research biobank. In addition, the current developments in information technology as well as automation solutions have enhanced the efficiency of the biobanking services. For instance, with the launch of fully automated programmed freezers as well as refrigerators, the temperature monitoring in biobanks has become far more efficient than before. Additionally, technological developments in biotechnology workflows have led to a growth in the applicatio...

  Biobanking Market The  biobanking market  size was valued USD 62.7 billion in 2021 and is expected to reach USD 98.1 billion by 2030 at 4.2% CAGR during the forecast period 2022-2030. Factors such as the increasing prevalence of chronic diseases and rising therapeutics demand are estimated to drive the market growth during the forecast period. Additionally, advancements in diagnostic and treatment technologies boost the market. However, low awareness and lack of healthcare services in the middle and low-income countries are estimated to restrain the market growth during the projected period. Major Key Players: Some of the key players in this market are Hamilton Company, Greiner Holding AG, Promega Corporation, Becton Dickinson and Company, Merck KGaA, VWR Corporation, Tecan Trading AG, Thermo Fisher Scientific Inc., Panasonic Healthcare Holdings Co., Ltd, Qiagen N.V., Brooks Automation, Inc., Chart Industries, Inc., and others. Segment Analysis The global biobanking mar...